Formosa Laboratories (TPE:4746) Enterprise Value: NT$8,486 Mil (As of Jul. 01, 2026) ***


TPE:4746 Formosa Laboratories Inc TPE:4746
70 GF Score
Price NT$53.70
GF Value NT$98.85
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Formosa Laboratories Enterprise Value?

Formosa Laboratories TPE:4746 -0.37% 70 Enterprise Value is NT$8,486 Mil as of Jul. 01, 2026. GuruFocus rates TPE:4746 with a GF Score™ of 70/100 and a GF Value™ of NT$98.85 (Possible Value Trap). The stock has 3 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Formosa Laboratories's Enterprise Value is NT$8,486 Mil. Formosa Laboratories's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was NT$535 Mil. Therefore, Formosa Laboratories's EV-to-EBIT ratio for today is 15.87.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Formosa Laboratories's Enterprise Value is NT$8,486 Mil. Formosa Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1,084 Mil. Therefore, Formosa Laboratories's EV-to-EBITDA ratio for today is 7.83.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Formosa Laboratories's Enterprise Value is NT$8,486 Mil. Formosa Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was NT$4,851 Mil. Therefore, Formosa Laboratories's EV-to-Revenue ratio for today is 1.75.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Formosa Laboratories's Enterprise Value is NT$8,486 Mil. Formosa Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1,315 Mil. Therefore, Formosa Laboratories's EV-to-OCF ratio for today is 6.45.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Formosa Laboratories's Enterprise Value is NT$8,486 Mil. Formosa Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$472 Mil. Therefore, Formosa Laboratories's EV-to-FCF ratio for today is 17.97.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Formosa Laboratories  (TPE:4746) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Formosa Laboratories's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=8486.144/534.874
=15.87

Formosa Laboratories's current Enterprise Value is NT$8,486 Mil.
Formosa Laboratories's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$535 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Formosa Laboratories's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=8486.144/1083.956
=7.83

Formosa Laboratories's current Enterprise Value is NT$8,486 Mil.
Formosa Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,084 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Formosa Laboratories's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8486.144/4851.357
=1.75

Formosa Laboratories's current Enterprise Value is NT$8,486 Mil.
Formosa Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$4,851 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Formosa Laboratories's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=8486.144/1315.247
=6.45

Formosa Laboratories's current Enterprise Value is NT$8,486 Mil.
Formosa Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,315 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Formosa Laboratories's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=8486.144/472.123
=17.97

Formosa Laboratories's current Enterprise Value is NT$8,486 Mil.
Formosa Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$472 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Formosa Laboratories Enterprise Value Related Terms


Formosa Laboratories Enterprise Value Historical Data

* Premium members only.

The historical data trend for Formosa Laboratories's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Formosa Laboratories Enterprise Value Chart

Formosa Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,811.00 11,284.81 14,459.28 10,433.19 9,220.36

Formosa Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,433.19 9,670.39 10,180.59 9,895.26 9,268.93

TPE:4746 vs ZTS, UTHR: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Formosa Laboratories's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formosa Laboratories Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Formosa Laboratories's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Formosa Laboratories's Enterprise Value falls into.


TPE:4746
70GF Score
Formosa Laboratories Inc TPE:4746
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Formosa Laboratories Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Formosa Laboratories's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Formosa Laboratories's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of NT$8,486 Mil mean?
Formosa Laboratories (TPE:4746) has a Enterprise Value of NT$8,486 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Formosa Laboratories and its competitors.
Is Formosa Laboratories' Enterprise Value too high?
Formosa Laboratories' current Enterprise Value is NT$8,486 Mil. Overall, Formosa Laboratories has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Formosa Laboratories' Enterprise Value compare to ZTS and UTHR?
Formosa Laboratories' Enterprise Value of NT$8,486 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Formosa Laboratories and its competitors. Formosa Laboratories's current Enterprise Value is NT$8,486 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formosa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Formosa Laboratories (TPE:4746) is currently considered Possible Value Trap. The stock's GF Value™ is NT$98.85, compared to a current price of NT$53.70 — trading 45.7% below its estimated fair value. The current Enterprise Value is NT$8,486 Mil. Formosa Laboratories' overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Formosa Laboratories (TPE:4746), the current Enterprise Value is NT$8,486 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Formosa Laboratories (TPE:4746) Overvalued in 2026?

Based on GuruFocus' analysis, Formosa Laboratories stock appears to be undervalued. The current stock price of NT$53.70 is trading 45.7% below its estimated GF Value™ of NT$98.85. GuruFocus considers Formosa Laboratories to be Possible Value Trap.

Key valuation signals for TPE:4746:

  • Enterprise Value: NT$8,486 Mil
  • GF Value™: NT$98.85 vs. price of NT$53.70 (45.7% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the TPE:4746 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Formosa Laboratories Business Description

Address No. 36-1, Heping Street, Luzhu disctrict, Taoyuan, TWN, 338002
Formosa Laboratories Inc is mainly engaged in the wholesale and manufacturing of active pharmaceutical ingredients, as well as ultraviolet absorbers. The company geographically operates in India, Taiwan, Netherlands, Switzerland, Germany, Japan, China, Canada, United States, and Others.
70GF Score

Get the complete analysis for TPE:4746

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$53.70
Price
NT$98.85
GF Value